- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05049304
Prevention With Oleanolic Acid of Insulin Resistance (PREOLIA)
September 10, 2021 updated by: Emilio Gonzalez Jimenez, Universidad de Granada
Prevention With Oleanolic Acid of Insulin Resistance and Metabolic Syndrome in Adolescents
Oleanolic acid (OA), a triterpene that is highly present in olive leaves, has been proposed as component of functional foods in the prevention of metabolic syndrome due to its anti-inflammatory activity.
In this research project we will study the presence of OA in postprandial TRL in healthy adolescents and in normal weight.
Moreover, THP-1 macrophages will be incubated with LPS for 48h after pretreatment with OA at different concentrations.
Also, TRL will be isolated from healthy adolescents before and 2 and 5h postprandially after the intake of a meal containing the functional olive oil or common olive oil and incubated with THP-1 macrophages.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Granada, Spain, 18016
- Faculty of Health Sciences (University of Granada)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
-Participants without digestive, metabolic or oncologic disorders or any other pathology
Exclusion Criteria:
-Not having the informed consent signed by the parents
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: OA-enriched functional olive oil
|
Eleven adolescents will consume OA-enriched functional olive oil.
After eating the olive oil, aliquots of cubital blood will be drawn at 2 and 5 hours of the postprandial period.
During that time, free access to water intake will be allowed.
|
|
Active Comparator: Olive oil not enriched in OA
|
Eleven adolescents will consume olive oil.
After eating the olive oil, aliquots of cubital blood will be drawn at 2 and 5 hours of the postprandial period.
During that time, free access to water intake will be allowed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pro-inflammatory cytokines
Time Frame: One year
|
The pro-inflammatory cytokines were studied in THP-1 macrophages stimulated with postprandial triglyceride-rich lipoproteins
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Actual)
September 14, 2020
Study Completion (Actual)
July 30, 2021
Study Registration Dates
First Submitted
September 10, 2021
First Submitted That Met QC Criteria
September 10, 2021
First Posted (Actual)
September 20, 2021
Study Record Updates
Last Update Posted (Actual)
September 20, 2021
Last Update Submitted That Met QC Criteria
September 10, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-AGR-287-UGR18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Sun Yat-sen UniversityNot yet recruitingMetabolic Syndrome Risk Factors | Metabolic Syndrome (MetS)China
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityRecruiting
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityEnrolling by invitationMetabolic Syndrome (MetS)China
-
National University Health System, SingaporeRecruitingMetabolic Syndrome | Metabolic Syndrome (MetS)Singapore
-
Hacettepe UniversityCompletedMetabolic Syndrome | Metabolic Syndrome Obesity | Metabolic Syndrome ParametersTurkey
-
Universidad de los Andes, ChileCompleted
-
University of KhartoumMinistry of Higher Education and Scientific Research, Republic of SudanCompletedMetabolic Syndrome in Postmenopausal FemalesSudan
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
University of Missouri-ColumbiaRecruitingGlucose Metabolism Disorders | Metabolic Syndrome | Metabolic Syndrome, Protection AgainstUnited States
-
Mayo ClinicCompleted
Clinical Trials on Functional olive oil
-
Spanish National Research CouncilAndalusian Health Service; Universidad Pablo de OlavideActive, not recruitingType II Diabetes Mellitus | Diabetic PatientsSpain
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Shandong Provincial HospitalNot yet recruitingUrinary Bladder NeoplasmsChina
-
University Rovira i VirgiliUniversitat de Lleida; Ministerio de Ciencia e Innovación, Spain; Fundacion IMIMUnknownPolyphenol Absorption in Healthy PeopleSpain
-
Fundación Pública Andaluza para la Investigación...Hospital del Mar; Instituto de Nutrición y Tecnología de los AlimentosUnknownCardiovascular DiseasesSpain
-
Harvard School of Public Health (HSPH)CompletedCardiovascular Disease
-
University of PeloponneseHarokopio University; University of the AegeanRecruitingAdults | Metabolic Abnormalities | Consented to Participate in the Trial and Signed an ICF | Overweight , ObesityGreece
-
Minia UniversityRecruitingOrthodontic Tooth MovementEgypt
-
University of LimerickCompletedCardiovascular Diseases | Obesity | DiabetesIreland
-
Chiayi Christian HospitalRecruitingChemo-radiotherapy | Oral Mucositis in Head and Neck CancerTaiwan
-
Université Catholique de LouvainCompleted